Cargando…
Clinical features and lipid metabolism genes as potential biomarkers in advanced lung cancer
BACKGROUND: Lung cancer is one of the most lethal tumors with a poor survival rate even in those patients receiving new therapies. Metabolism is considered one of the hallmarks in carcinogenesis and lipid metabolism is emerging as a significant contributor to tumor metabolic reprogramming. We previo...
Autores principales: | Merino Salvador, María, Fernández, Lara Paula, Moreno-Rubio, Juan, Colmenarejo, Gonzalo, Casado, Enrique, Ramírez de Molina, Ana, Sereno, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830782/ https://www.ncbi.nlm.nih.gov/pubmed/36624406 http://dx.doi.org/10.1186/s12885-023-10509-x |
Ejemplares similares
-
Metabolic Health Together with a Lipid Genetic Risk Score Predicts Survival of Small Cell Lung Cancer Patients
por: Fernández, Lara P., et al.
Publicado: (2021) -
Metabolic enzyme ACSL3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non‐small cell lung cancer
por: Fernández, Lara Paula, et al.
Publicado: (2020) -
Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic
por: Bouzas, Adrián, et al.
Publicado: (2022) -
Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer
por: Moreno-Rubio, Juan, et al.
Publicado: (2020) -
Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer
por: Aguirre-Portolés, Cristina, et al.
Publicado: (2017)